De Novo proteomics of neuronal ischemic tolerance

An Zhou, Larry David, Roger Simon

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

In a recent proteomic characterization of ischemic-tolerant rodent brains, we discovered an enriched presence of repressive transcriptional regulator proteins with essential roles as epigenetic regulators inducing tolerance to ischemia in brain (1). We further showed their robust, dynamic and differential changes under different ischemic conditions in brain. In the present work, we aimed to characterize the de novo proteome, the proteome that presents early during the induction of ischemic tolerance. These would be the proteomic changes of newly synthesized proteins at the initiation of the tolerant phenotype. Identification of effectors of this phase of tolerance induction bears the best promise of identifying therapeutic targets for treating acute stroke when patients present to hospital. We compare these de novo results to those in fully developed tolerant brains.

Original languageEnglish (US)
Title of host publication2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010
Pages552-555
Number of pages4
DOIs
StatePublished - 2010
Event2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010 - Niagara Falls, NY, United States
Duration: Aug 2 2010Aug 4 2010

Other

Other2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010
CountryUnited States
CityNiagara Falls, NY
Period8/2/108/4/10

Fingerprint

Proteomics
Brain
Proteome
Proteins
Brain Ischemia
Epigenomics
Rodentia
Stroke
Phenotype
Therapeutics

Keywords

  • Gene ontology
  • Proteomics
  • Transcription network

ASJC Scopus subject areas

  • Biomedical Engineering
  • Health Information Management

Cite this

Zhou, A., David, L., & Simon, R. (2010). De Novo proteomics of neuronal ischemic tolerance. In 2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010 (pp. 552-555) https://doi.org/10.1145/1854776.1854880

De Novo proteomics of neuronal ischemic tolerance. / Zhou, An; David, Larry; Simon, Roger.

2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010. 2010. p. 552-555.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Zhou, A, David, L & Simon, R 2010, De Novo proteomics of neuronal ischemic tolerance. in 2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010. pp. 552-555, 2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010, Niagara Falls, NY, United States, 8/2/10. https://doi.org/10.1145/1854776.1854880
Zhou A, David L, Simon R. De Novo proteomics of neuronal ischemic tolerance. In 2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010. 2010. p. 552-555 https://doi.org/10.1145/1854776.1854880
Zhou, An ; David, Larry ; Simon, Roger. / De Novo proteomics of neuronal ischemic tolerance. 2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010. 2010. pp. 552-555
@inproceedings{3e7eb312ba8f4740b13a858451fca55a,
title = "De Novo proteomics of neuronal ischemic tolerance",
abstract = "In a recent proteomic characterization of ischemic-tolerant rodent brains, we discovered an enriched presence of repressive transcriptional regulator proteins with essential roles as epigenetic regulators inducing tolerance to ischemia in brain (1). We further showed their robust, dynamic and differential changes under different ischemic conditions in brain. In the present work, we aimed to characterize the de novo proteome, the proteome that presents early during the induction of ischemic tolerance. These would be the proteomic changes of newly synthesized proteins at the initiation of the tolerant phenotype. Identification of effectors of this phase of tolerance induction bears the best promise of identifying therapeutic targets for treating acute stroke when patients present to hospital. We compare these de novo results to those in fully developed tolerant brains.",
keywords = "Gene ontology, Proteomics, Transcription network",
author = "An Zhou and Larry David and Roger Simon",
year = "2010",
doi = "10.1145/1854776.1854880",
language = "English (US)",
isbn = "9781450304382",
pages = "552--555",
booktitle = "2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010",

}

TY - GEN

T1 - De Novo proteomics of neuronal ischemic tolerance

AU - Zhou, An

AU - David, Larry

AU - Simon, Roger

PY - 2010

Y1 - 2010

N2 - In a recent proteomic characterization of ischemic-tolerant rodent brains, we discovered an enriched presence of repressive transcriptional regulator proteins with essential roles as epigenetic regulators inducing tolerance to ischemia in brain (1). We further showed their robust, dynamic and differential changes under different ischemic conditions in brain. In the present work, we aimed to characterize the de novo proteome, the proteome that presents early during the induction of ischemic tolerance. These would be the proteomic changes of newly synthesized proteins at the initiation of the tolerant phenotype. Identification of effectors of this phase of tolerance induction bears the best promise of identifying therapeutic targets for treating acute stroke when patients present to hospital. We compare these de novo results to those in fully developed tolerant brains.

AB - In a recent proteomic characterization of ischemic-tolerant rodent brains, we discovered an enriched presence of repressive transcriptional regulator proteins with essential roles as epigenetic regulators inducing tolerance to ischemia in brain (1). We further showed their robust, dynamic and differential changes under different ischemic conditions in brain. In the present work, we aimed to characterize the de novo proteome, the proteome that presents early during the induction of ischemic tolerance. These would be the proteomic changes of newly synthesized proteins at the initiation of the tolerant phenotype. Identification of effectors of this phase of tolerance induction bears the best promise of identifying therapeutic targets for treating acute stroke when patients present to hospital. We compare these de novo results to those in fully developed tolerant brains.

KW - Gene ontology

KW - Proteomics

KW - Transcription network

UR - http://www.scopus.com/inward/record.url?scp=77958061592&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958061592&partnerID=8YFLogxK

U2 - 10.1145/1854776.1854880

DO - 10.1145/1854776.1854880

M3 - Conference contribution

SN - 9781450304382

SP - 552

EP - 555

BT - 2010 ACM International Conference on Bioinformatics and Computational Biology, ACM-BCB 2010

ER -